Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.43 |
| ▸ | CA2 | P00918 | 3/20 | 0.43 |
| ▸ | CA9 | Q16790 | 2/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | NFE2L2 | Q16236 | 13/20 | 0.42 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | SLC40A1 | Q9NP59 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9734435 | 0.79 | TRPV4 (0.42) | NFE2L2SLC40A1 | |
| SCHEMBL5029453 | 0.79 | NFE2L2 (0.42) | NFE2L2KDM4ESLC40A1 | |
| SCHEMBL390770 | 0.77 | KMT2A (0.56) | CA1CA2CA9MAPK1FTO | |
| SCHEMBL10480797 | 0.77 | CA1 (0.58) | CA1CA2CA9MAPK1FTO | |
| SCHEMBL14120534 | 0.77 | CA2 (0.45) | CA1CA2CA9MAPK1FTO | |
| SCHEMBL8537341 | 0.77 | FTO (0.49) | CA1CA2CA9MAPK1FTO | |
| SCHEMBL27327132 | 0.76 | NFE2L2 (0.44) | NFE2L2KMT2ASLC40A1 | |
| SCHEMBL30727180 | 0.76 | NFE2L2 (0.44) | NFE2L2KMT2ASLC40A1 | |
| SCHEMBL6098339 | 0.75 | LMNA (0.50) | CA1CA2CA9MAPK1NFE2L2 | |
| SCHEMBL3636398 | 0.75 | NOS3 (0.48) | CA1CA2CA9MAPK1FTO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109641873-B | N- (pyridin-2-yl) pyridine-sulfonamide derivatives and their use for the treatment of disease | 诺华股份有限公司 | 2022-03-18 | — | — | CN | disclosed |
| CN-113226464-A | N- (pyridin-2-ylsulfonyl) cyclopropanecarboxamide derivatives and their use in the treatment of CFTR mediated diseases | 诺华股份有限公司 | 2021-08-06 | — | — | CN | disclosed |
| US-10844013-B2 | Phenyl amino piperidine mTORC inhibitors and uses thereof | NAVITOR PHARMACEUTICALS, INC. (US) | 2020-11-24 | — | — | US | disclosed |
| US-10844013-B2 | Phenyl amino piperidine mTORC inhibitors and uses thereof | NAVITOR PHARMACEUTICALS, INC. (US) | 2020-11-24 | — | — | US | disclosed |
| US-20200207716-A1 | PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF | NAVITOR PHARMACEUTICALS, INC. | 2020-07-02 | — | — | US | disclosed |
| US-20200207716-A1 | PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF | NAVITOR PHARMACEUTICALS, INC. | 2020-07-02 | — | — | US | disclosed |
| EP-3538091-A1 | PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF | Navitor Pharmaceuticals, Inc. (US) | 2019-09-18 | — | — | EP | disclosed |
| US-10414727-B2 | Phenyl amino piperidine mTORC inhibitors and uses thereof | NAVITOR PHARMACEUTICALS, INC. (US) | 2019-09-17 | — | — | US | disclosed |
| US-10414727-B2 | Phenyl amino piperidine mTORC inhibitors and uses thereof | NAVITOR PHARMACEUTICALS, INC. (US) | 2019-09-17 | — | — | US | disclosed |
| WO-2018089499-A1 | PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF | NAVITOR PHARMACEUTICALS, INC. (US) | 2018-05-17 | — | — | WO | disclosed |
| US-5403814-A | Preemergence and postemergence herbicides | CIBA-GEIGY CORPORATION (US) | 1995-04-04 | — | — | US | disclosed |
| US-5352654-A | Pre- and post-emergence herbicides, plant growth regulators | CIBA-GEIGY CORPORATION (US) | 1994-10-04 | — | — | US | disclosed |
| EP-0402316-B1 | Sulphonylureas | CIBA GEIGY AG (CH) | 1994-09-14 | — | — | EP | disclosed |
| US-5336773-A | Herbicides; plant growth regulators | CIBA-GEIGY CORPORATION (US) | 1994-08-09 | — | — | US | disclosed |
| WO-1993017015-A1 | SULFONYLUREAS AS HERBICIDES | CIBA-GEIGY AG (CH) | 1993-09-02 | — | — | WO | disclosed |
| US-5221315-A | Herbicides and plant growth regulators | CIBA-GEIGY CORPORATION (US) | 1993-06-22 | — | — | US | disclosed |
| EP-0540697-A1 | NOVEL SULFONYLUREAS | Novartis AG (CH) | 1993-05-12 | — | — | EP | disclosed |
| WO-1992016522-A1 | NOVEL SULFONYLUREAS | CIBA-GEIGY AG (CH) | 1992-10-01 | — | — | WO | disclosed |
| EP-0459949-A1 | Sulfonyl ureas with herbicidal activity and useful as plant growth regulators | CIBA-GEIGY AG (CH) | 1991-12-04 | — | — | EP | disclosed |
| EP-0402316-A1 | Sulphonylureas | CIBA-GEIGY AG (CH) | 1990-12-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10844013-B2 | Phenyl amino piperidine mTORC inhibitors and uses thereof | MTOR, RICTOR, RPTOR | CA1 4540/4885CA2 3770/4885CA9 4552/4885 |
| US-10414727-B2 | Phenyl amino piperidine mTORC inhibitors and uses thereof | MTOR, RICTOR, RPTOR | CA1 4540/4885CA2 3770/4885CA9 4552/4885 |
| US-20200207716-A1 | PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF | MTOR, RICTOR, RPTOR | CA1 4540/4885CA2 3770/4885CA9 4552/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.